SARS-CoV-2 viral load and shedding kinetics

被引:290
作者
Puhach, Olha [1 ]
Meyer, Benjamin [2 ]
Eckerle, Isabella [1 ,3 ,4 ]
机构
[1] Univ Geneva, Fac Med, Dept Med, Geneva, Switzerland
[2] Univ Geneva, Ctr Vaccinol, Dept Pathol & Immunol, Geneva, Switzerland
[3] Geneva Univ Hosp, Geneva Ctr Emerging Viral Dis, Geneva, Switzerland
[4] Geneva Univ Hosp, Div Infect Dis, Geneva, Switzerland
基金
瑞士国家科学基金会;
关键词
ACUTE RESPIRATORY SYNDROME; CORONAVIRUS DISEASE 2019; CYCLE THRESHOLD VALUES; TRANSMISSION DYNAMICS; INCUBATION PERIOD; HONG-KONG; INFECTION; COVID-19; VIRUS; SARS;
D O I
10.1038/s41579-022-00822-w
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
SARS-CoV-2 viral load and detection of infectious virus in the respiratory tract are the two key parameters for estimating infectiousness. As shedding of infectious virus is required for onward transmission, understanding shedding characteristics is relevant for public health interventions. Viral shedding is influenced by biological characteristics of the virus, host factors and pre-existing immunity (previous infection or vaccination) of the infected individual. Although the process of human-to-human transmission is multifactorial, viral load substantially contributed to human-to-human transmission, with higher viral load posing a greater risk for onward transmission. Emerging SARS-CoV-2 variants of concern have further complicated the picture of virus shedding. As underlying immunity in the population through previous infection, vaccination or a combination of both has rapidly increased on a global scale after almost 3 years of the pandemic, viral shedding patterns have become more distinct from those of ancestral SARS-CoV-2. Understanding the factors and mechanisms that influence infectious virus shedding and the period during which individuals infected with SARS-CoV-2 are contagious is crucial to guide public health measures and limit transmission. Furthermore, diagnostic tools to demonstrate the presence of infectious virus from routine diagnostic specimens are needed.
引用
收藏
页码:147 / 161
页数:15
相关论文
共 209 条
[1]   Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong [J].
Adam, Dillon C. ;
Wu, Peng ;
Wong, Jessica Y. ;
Lau, Eric H. Y. ;
Tsang, Tim K. ;
Cauchemez, Simon ;
Leung, Gabriel M. ;
Cowling, Benjamin J. .
NATURE MEDICINE, 2020, 26 (11) :1714-+
[2]   Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2 [J].
Afkhami, Sam ;
D'Agostino, Michael R. ;
Zhang, Ali ;
Stacey, Hannah D. ;
Marzok, Art ;
Kang, Alisha ;
Singh, Ramandeep ;
Bavananthasivam, Jegarubee ;
Ye, Gluke ;
Luo, Xiangqian ;
Wang, Fuan ;
Ang, Jann C. ;
Zganiacz, Anna ;
Sankar, Uma ;
Kazhdan, Natallia ;
Koenig, Joshua F. E. ;
Phelps, Allyssa ;
Gameiro, Steven F. ;
Tang, Shangguo ;
Jordana, Manel ;
Wan, Yonghong ;
Mossman, Karen L. ;
Jeyanathan, Mangalakumari ;
Gillgrass, Amy ;
Medina, Maria Fe C. ;
Smaill, Fiona ;
Lichty, Brian D. ;
Miller, Matthew S. ;
Xing, Zhou .
CELL, 2022, 185 (05) :896-+
[3]  
Albert, 2020, CLIN MICROBIOL INFEC, DOI [10.1101/2020.10.16.20213850, DOI 10.1016/J.CMI.2020.11.004]
[4]   SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication [J].
Alexandersen, Soren ;
Chamings, Anthony ;
Bhatta, Tarka Raj .
NATURE COMMUNICATIONS, 2020, 11 (01)
[5]  
Alihsan B., 2022, PREPRINT, DOI [10.1101/2022.07.28.22278153, DOI 10.1101/2022.07.28.22278153]
[6]   Superspreading events in the transmission dynamics of SARS-CoV-2: Opportunities for interventions and control [J].
Althouse, Benjamin M. ;
Wenger, Edward A. ;
Miller, Joel C. ;
Scarpino, Samuel V. ;
Allard, Antoine ;
Hebert-Dufresne, Laurent ;
Hu, Hao .
PLOS BIOLOGY, 2020, 18 (11)
[7]   Test-trace-isolate-quarantine (TTIQ) intervention strategies after symptomatic COVID-19 case identification [J].
Ashcroft, Peter ;
Lehtinen, Sonja ;
Bonhoeffer, Sebastian .
PLOS ONE, 2022, 17 (02)
[8]   Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer [J].
Aydillo, Teresa ;
Babady, N. Esther ;
Kamboj, Mini .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (26) :2586-2588
[9]   Shorter serial intervals in SARS-CoV-2 cases with Omicron BA.1 variant compared with Delta variant, the Netherlands, 13 to 26 December 2021 [J].
Backer, Jantlen A. ;
Eggink, Dirk ;
Andeweg, Stijn P. ;
Veldhuizen, Irene K. ;
van Maarseveen, Noortje ;
Vermaas, Klaas ;
Vlaemynck, Boris ;
Schepers, Raf ;
van den Hof, Susan ;
Reusken, Chantal B. E. M. ;
Wallinga, Jacco .
EUROSURVEILLANCE, 2022, 27 (06)
[10]   Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [J].
Baden, Lindsey R. ;
El Sahly, Hana M. ;
Essink, Brandon ;
Kotloff, Karen ;
Frey, Sharon ;
Novak, Rick ;
Diemert, David ;
Spector, Stephen A. ;
Rouphael, Nadine ;
Creech, C. Buddy ;
McGettigan, John ;
Khetan, Shishir ;
Segall, Nathan ;
Solis, Joel ;
Brosz, Adam ;
Fierro, Carlos ;
Schwartz, Howard ;
Neuzil, Kathleen ;
Corey, Larry ;
Gilbert, Peter ;
Janes, Holly ;
Follmann, Dean ;
Marovich, Mary ;
Mascola, John ;
Polakowski, Laura ;
Ledgerwood, Julie ;
Graham, Barney S. ;
Bennett, Hamilton ;
Pajon, Rolando ;
Knightly, Conor ;
Leav, Brett ;
Deng, Weiping ;
Zhou, Honghong ;
Han, Shu ;
Ivarsson, Melanie ;
Miller, Jacqueline ;
Zaks, Tal .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :403-416